Endothelial dysfunction in neurodegenerative diseases
YC Fang, YC Hsieh, CJ Hu, YK Tu - International journal of molecular …, 2023 - mdpi.com
The cerebral vascular system stringently regulates cerebral blood flow (CBF). The
components of the blood–brain barrier (BBB) protect the brain from pathogenic infections …
components of the blood–brain barrier (BBB) protect the brain from pathogenic infections …
An overview on the biological activity and anti-cancer mechanism of lovastatin
L Xie, G Zhu, J Shang, X Chen, C Zhang, X Ji, Q Zhang… - Cellular …, 2021 - Elsevier
Lovastatin, a secondary metabolite isolated from fungi, is often used as a representative
drug to reduce blood lipid concentration and treat hypercholesterolemia. Its structure is …
drug to reduce blood lipid concentration and treat hypercholesterolemia. Its structure is …
Cholesterol and statins in Alzheimer's disease: current controversies
ACRG Fonseca, R Resende, CR Oliveira… - Experimental …, 2010 - Elsevier
Alzheimer's disease (AD) is the principal cause of dementia in older people, and
accumulation of amyloid-beta (Aβ) peptide is a crucial event in AD pathogenesis. Despite …
accumulation of amyloid-beta (Aβ) peptide is a crucial event in AD pathogenesis. Despite …
Production of valuable compounds by molds and yeasts
AL Demain, E Martens - The Journal of antibiotics, 2017 - nature.com
We are pleased to dedicate this paper to Dr Julian E Davies. Julian is a giant among
microbial biochemists. He began his professional career as an organic chemistry PhD …
microbial biochemists. He began his professional career as an organic chemistry PhD …
Simvastatin is the statin that most efficiently protects against kainate-induced excitotoxicity and memory impairment
C Ramirez, I Tercero, A Pineda… - Journal of Alzheimer's …, 2011 - content.iospress.com
Statins have recently been shown to act as protectants against several neuropathological
conditions. They have received special attention in the field of Alzheimer's disease (AD) …
conditions. They have received special attention in the field of Alzheimer's disease (AD) …
Amyloid-beta disrupts calcium and redox homeostasis in brain endothelial cells
ACRG Fonseca, PI Moreira, CR Oliveira… - Molecular …, 2015 - Springer
In Alzheimer's disease, the accumulation of amyloid-beta (Aβ) in the brain occurs in the
parenchyma and cerebrovasculature. Several evidences support that the neuronal demise …
parenchyma and cerebrovasculature. Several evidences support that the neuronal demise …
Neurovascular and cognitive failure in Alzheimer's disease: benefits of cardiovascular therapy
E Hamel, J Royea, B Ongali, XK Tong - Cellular and molecular …, 2016 - Springer
Alzheimer's disease (AD) is a multifactorial and multifaceted disease for which we currently
have very little to offer since there is no curative therapy, with only limited disease-modifying …
have very little to offer since there is no curative therapy, with only limited disease-modifying …
Valuable secondary metabolites from fungi
AL Demain - Biosynthesis and molecular genetics of fungal …, 2014 - Springer
Fungi are amazing producers of natural products, including secondary metabolites. These
compounds are crucial to the health and well-being of people throughout the world. They …
compounds are crucial to the health and well-being of people throughout the world. They …
Neurocytoprotective Effects of Aliphatic Hydroxamates from Lovastatin, a Secondary Metabolite from Monascus-Fermented Red Mold Rice, in 6-Hydroxydopamine (6 …
CM Lin, YT Lin, RD Lin, WJ Huang… - ACS Chemical …, 2015 - ACS Publications
Lovastatin, a secondary metabolite isolated from Monascus-fermented red rice mold, has
neuroprotective activity and permeates the blood–brain barrier. The aim of this study was to …
neuroprotective activity and permeates the blood–brain barrier. The aim of this study was to …
The role of caspases in Alzheimer's disease: pathophysiology implications and pharmacologic modulation
MR Khezri… - Journal of Alzheimer's …, 2023 - content.iospress.com
Alzheimer's disease (AD) is the most common neurodegenerative disorder worldwide.
Although the main cause of the onset and development of AD is not known yet, neuronal …
Although the main cause of the onset and development of AD is not known yet, neuronal …